Barclays Initiates Coverage On LivaNova with Overweight Rating, Announces Price Target of $105

Benzinga Newsdesk www.benzinga.com Positive 53.3%

Neg 0% Neu 0% Pos 53.3%

Barclays analyst Christopher Pasquale initiates coverage on LivaNova (NASDAQ:LIVN) with a Overweight rating and announces Price Target of $105.